Lumosad, Marebeb M.

HRN: 22-80-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2023
CEFAZOLIN 1GM (VIAL)
04/02/2023
04/03/2023
IVTT
2g
Prior To OR
For D&C
Waiting Final Action 
04/03/2023
CEFUROXIME 500MG (TAB)
04/03/2023
04/10/2023
PER OREM
500 Mg
Twice A Day
S/p Dilatation And Curettage
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: